Abstract Jimpy (Plp jp ) is an X-linked recessive mutation in mice that causes CNS dysmyelination and early death in affected males. It results from a point mutation in the acceptor splice site of myelin proteolipid protein (Plp) exon 5, producing transcripts that are missing exon 5, with a concomitant shift in the downstream reading frame. Expression of the mutant PLP product in Plp jp males leads to hypomyelination and oligodendrocyte death. Expression of our Plp-lacZ fusion gene, PLP(+)Z, in transgenic mice is an excellent readout for endogenous Plp transcriptional activity. The current studies assess expression of the PLP(+)Z transgene in the Plp jp background. These studies demonstrate that expression of the transgene is decreased in both the central and peripheral nervous systems of affected Plp jp males. Thus, expression of mutated PLP protein downregulates Plp gene activity both in oligodendrocytes, which eventually die, and in Schwann cells, which are apparently unaffected in Plp jp mice.
Introduction
Dysmyelinating disorders such as Pelizaeus-Merzbacher disease in humans or the jimpy Plp mutation in mice are characterized by dramatically altered oligodendrocyte differentiation and brain function, which result from mutations in the myelin proteolipid protein (Plp) gene [reviewed in 1, 2] . A point mutation in the acceptor splice site of exon 5 in the jimpy Plp gene (Plp jp ) results in deletion of this exon from Plp/ Dm20 transcripts and a concomitant frameshift and truncation of the C-terminal amino acids [3, 4] . In very young animals, the transcription rate of the Plp jp gene is similar to that in mice containing the wild-type gene. However, as development proceeds, Plp gene transcription in the mutant does not increase as it does in wild-type mice [5] . In addition, the Plp jp mutation exhibits pleiotropic effects, for example, reducing the transcription rate of the myelin basic protein (Mbp) gene, which is expressed later in the oligodendrocyte differentiation pathway. Other point mutations in the Plp gene, resulting in both conservative and non-conservative amino acid substitutions, have been identified, which generally cause developmental disorders that are similar to that caused by the Plp jp mutation [6] [7] [8] . On the whole, Plp gene mutations are far more devastating than mutations in other genes that cause dysmyelination. Mice and rats with Plp mutations generally die within 3-4 weeks after birth, while shiverer, quaking and trembler mice survive to adulthood. Mutant PLP proteins tend to accumulate in the endoplasmic reticulum of oligodendrocyte cell bodies [9] , and it is proposed that the defective protein activates the unfolded protein response, culminating in oligodendrocyte cell death [10] . The greater lethality of these mutations, however, likely results from expression of mutated PLP in neurons in the brainstem, which leads to dramatic respiratory depression in response to hypoxia [11] .
The current studies were designed to investigate the effects of the Plp jp mutation on Plp gene expression in both the CNS and PNS, using a transgenic mouse model in which expression of the lacZ reporter gene is governed by Plp genomic sequences. The PLP(+)Z transgene contains the proximal 2.4 kb of 5¢-flanking DNA, exon 1, intron 1 and the first 37 bp of exon 2 of the Plp gene, and encodes a fusion protein between the first 13 amino acids of PLP and b-galactosidase (b-gal), which is trafficked to the myelin membrane [12] . A series of transgenic animals have subsequently been derived that further corroborate the ability of these Plp sequences to promote transgene expression, and to serve as a reliable readout of endogenous Plp gene activity [13] [14] [15] [16] [17] [18] , with inclusion of Plp intron 1 sequences being important [19] . In the current studies, the PLP(+)Z transgene was crossed into the Plp jp background and used to monitor the effects of the Plp jp mutation on Plp promoter activity via lacZ reporter gene expression.
Methods

Animals
The studies were conducted on transgenic mice that express the Plp-lacZ fusion gene, PLP(+)Z [12] . The transgene encodes a protein containing the first 13 amino acids of PLP fused to b-gal. Male mice, homozygous for the PLP(+)Z transgene (line 26H), were bred to non-transgenic Plp jp female carriers (heterozygous Plp jp females). Thus, all of the resulting progeny were heterozygous for the PLP(+)Z transgene. Genomic DNA was isolated from tail biopsies as previously described [12] 
b-Galactosidase histochemistry
Cells expressing the PLP(+)Z transgene were identified in tissue sections from mouse brain using b-gal chromogenic substrates (X-gal or Bluo-gal) as previously described [12] , except that 1.0% glutaraldehyde in PBS (pH 7.3) was the fixative. The Bluo-gal substrate was used for analysis of cryostat sections at high magnification since the blue reaction product does not diffuse out of cells. Thus, better cell morphology can be assessed with this stain.
Immunohistochemistry
Mice at 21 days of age (P21) were perfused with 4% paraformaldehyde in PBS (pH 7.6) under halothane anesthesia. Tissues were removed, post-fixed for 24 h in 4% paraformaldehyde and cryoprotected in 20% glycerol. Tissue samples were sectioned on a sliding microtome. Sections (30 lm) were immunostained according to the methods of Bö et al. [20] . Freefloating sections were pretreated in 0.1% OsO 4 
Western blot analysis
Lysates for Western blot analysis comparing proteins from brain and spinal cord were prepared by homogenization of tissues in 4% SDS (1:20 wt:vol). Proteins were fractionated on a 10% polyacrylamide gel (SDS-PAGE) [22] and analyzed using the ECL kit (Amersham, Piscataway, NJ). Blots were incubated with PLP-specific (M2) and b-gal (Cortex) anti-rabbit polyclonal antibodies, overnight at 4°C. The blots were then washed and incubated with secondary antibody at a dilution of 1:5,000 for 2 h at room temperature.
Tissue lysates for Western blot analysis comparing proteins from brain and sciatic nerve were prepared in Lysis Buffer (0.15 M NaCl, 0.05 M Tris, 0.5 mM EDTA, 1% Triton X-100, 0.05% SDS, pH 7.5) supplemented with protease inhibitors (20 g/ml leupeptin, 100 g/ml aprotinin, 2 mM PMSF, 5 mM NEM). After 1 h on ice, samples were centrifuged at 15,000 · g for 10 min to remove insoluble material. Protein concentration in the supernatants was determined using the bicinchoninic acid method (Sigma, St. Louis, MO). Proteins were separated on a 10% polyacrylamide gel (SDS-PAGE) and transferred to a PVDF membrane. The blots were blocked with 5% non-fat dry milk in TBS-T buffer (10 mM Tris, 150 mM NaCl, 0.2% Tween 20, pH 8.0) overnight at 4°C and subsequently incubated with primary rabbit antibody against PLP, b-gal, MBP (Sternberger Monoclonals) or b-actin (Sigma,) for 1 h at room temperature. After washing, the blots were incubated with secondary antibody for 1 h at room temperature. Immunoreactive bands were visualized using ECL Plus detection reagents (Amersham).
RT-PCR analysis
Total RNA was isolated by the procedure of Chomczynski and Sacchi [23] . Reverse transcription (RT) was performed using the SuperScript FirstStrand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA). PCR primer pairs were (1) Plp/ Dm20: sense 5¢-CCAAAAACTACCAGGACTA-3¢ and antisense 5¢-TCAGAGACGCGACTACGGT-3¢ generating products of 459-bp (Plp) and 354-bp (Dm20); (2) lacZ: sense 5¢-GTGCGGATTGAAAA-TGGTCT-3¢ and antisense 5¢-CACCGCATCAGCA-AGTGTAT-3¢ generating a 1,500-bp product; (3) a-tubulin: sense 5¢-CGTGAGTGCATCTCCATC-CAT-3¢ and antisense 5¢-GCCCTCACCCACATAC-CAGTG-3¢ generating a 1,233-bp product.
Results
PLP(+)Z transgene expression in the developing CNS in Plp jp mice
Expression of the PLP(+)Z transgene was evaluated in the Plp dysmyelinating mouse mutant, Plp jp . The transgene contains Plp genomic DNA extending from the proximal 2.4 kb of 5¢-flanking DNA, downstream to the first 37 bp of exon 2, which were used to drive expression of a lacZ reporter gene cassette. Thus the transgene contains the Plp promoter as well as a tissuespecific enhancer located in Plp intron 1 DNA [24, 25] . Expression of the PLP(+)Z transgene was evaluated in affected Plp jp males, which express a mutated Plp gene (Plp jp ), and compared to that produced in wild-type male littermates containing the normal Plp gene. In some cases, transgene expression was also measured in heterozygous Plp jp female carriers (Plp jp/+ ). As shown in Fig. 1 In order to further assess the reduction of transgene expression in the Plp jp background, Western blot analysis was performed with brain and spinal cord lysates. As shown in Fig. 2 , the levels of PLP and b-gal were greatly reduced in the CNS of Plp jp males, compared to those present in wild-type males and Plp jp female carriers. Heterozygous Plp jp females demonstrated diminished amounts of both proteins at P7 (particularly in the spinal cord), but by P14, the levels of PLP and b-gal were comparable to those in wildtype males. Plp jp males expressed low, but detectable, amounts of b-gal protein, however PLP was not detected by Western blot analysis, presumably due to altered folding of the mutant protein and likely aggregation and/or degradation.
To better examine the morphology of cells expressing the transgene at high magnification, brain sections were stained with the b-gal substrate, Bluo-gal. Bluogal stained cells (oligodendrocytes) in the wild-type background had a stellate appearance at P5 (Fig. 3A) and exhibited large b-gal-expressing tracts, with little staining in cell bodies by P12 (Fig. 3B ). Yet even at P21, b-gal expressing cells in the Plp jp male were morphologically similar to immature oligodendrocytes present in wild-type littermates at P5, staining predominantly the multiple short processes of mutant cells, with little staining in cell bodies (Fig. 3C) .
Immunocytochemical analysis confirmed a decrease in PLP(+)Z expression in the Plp jp background. When compared to age-matched wild-type males, P21 Plp jp males exhibited a dramatic decrease in both PLP and b-gal immunoreactivity in all regions examined, and MBP and CNP immunostaining was also decreased in affected males, although not as severely as for PLP and b-gal (data not shown). As seen at high magnification, the little PLP remaining was localized almost exclusively in the cell body of Plp jp oligodendrocytes (Fig. 4A) , whereas in mature wild-type oligodendrocytes, localization of PLP to the cell body was rarely seen (data not shown). In sharp contrast, the b-gal transgene product in Plp jp mice was found in short oligodendrocyte processes and fibers, and only occasionally in cell bodies (Fig. 4B) . CNP staining was observed in both the cell body and short fibers of 
Plp
jp oligodendrocytes (Fig. 4C) . Even though less CNP was expressed in oligodendrocytes from the Plp jp mutant, the distribution of CNP within the cell was similar to that in wild-type animals (data not shown).
Double labeling for PLP and b-gal in Plp jp oligodendrocytes demonstrated significant partitioning of the proteins (Fig. 5) . The PLP protein appeared to be restricted to the Plp jp oligodendrocyte cell body, while b-gal was detected predominantly along the processes and short fibers, with occasional cells having stain in the cell body. As seen in other studies [9, 10] , it is likely that the mutant PLP protein is accumulating in the cell body. In contrast, the b-gal fusion protein, which contains the first 13 amino acids of PLP at its N-terminus and is targeted to compact myelin in wild-type mice [12] , does not remain in the cell body and gets properly trafficked to the plasma membrane.
PLP(+)Z transgene expression in the PNS in Plp jp
mice Transgene expression was also investigated in the PNS of Plp jp and wild-type males. As shown in Fig. 6 , the amounts of both PLP and b-gal in sciatic nerve were decreased in Plp jp sciatic nerve, similar to that in brain. However unlike the CNS, the Plp jp mutation did not display pleiotropic effects in the PNS, as evidenced by equivalent amounts of MBP in sciatic nerve from Plp jp and wild-type males (Fig. 6) .
Plp/Dm20 and lacZ mRNA levels in the CNS and PNS were also analyzed semi-quantitatively by RT-PCR, which permits analysis of both Plp and Dm20 mRNAs (Fig. 7) . In brain, the amounts of Plp/Dm20 mRNA were higher than lacZ in both wild-type and Plp jp males. Interestingly, lacZ mRNA levels in sciatic nerve were higher than either Plp or Dm20 mRNA in both wild-type and Plp jp males at P21. This may partially reflect the presence of two pools of alternative splice products (Plp/Dm20), while there is only one for PLP(+)Z transgene mRNA, although this does not impact their absolute expression in brain. Brain Plp mRNA levels were approximately 20-fold less in Plp compared to wild-type males, e.g., comparable amounts of Plp-specific RT-PCR products were generated using cDNA reaction mixture inputs of 50 ng for wild-type and 1 lg for Plp jp (Fig. 7) . The amount of lacZ mRNA in Plp jp brain was decreased to an even greater extent. By contrast, in sciatic nerve, Plp/Dm20 mRNA levels were decreased less than 4-fold in Plp The current studies demonstrate that Plp genomic sequences contained within PLP(+)Z, which regulate expression of the PLP(+)Z transgene comparably to the endogenous Plp gene, downregulate expression of the Plp gene in both the CNS and the PNS in Plp jp mice, relative to wild-type mice. This is to be expected in the CNS. Plp jp mice, which express a mutant form of PLP due to a point mutation in the acceptor splice site of exon 5, have significant alterations in the oligodendrocyte cell cycle, where a high mitotic rate is observed accompanied by significant cell death [29] [30] [31] [32] . Campagnoni's group showed two decades ago that PLP protein and mRNA are dramatically downregulated in Plp jp mice [33] [34] [35] . Additionally, it has been known for some time that both Plp and Mbp transcriptional activity is decreased in the brains of affected males [5, 36] . While the obvious assumption has been that the mutant PLP protein is responsible for this change, it is possible that the point mutation itself could have had a cis effect on Plp gene activity. The current studies conclusively disprove this, since expression of the PLP(+)Z transgene, which does not contain the Plp jp point mutation, is likewise decreased in the Plp jp CNS relative to wild-type. Perhaps the reduction in transgene expression simply reflects the fact that Plp jp oligodendrocytes are compromised, triggering higher levels of cell death, and thus reducing their overall number in affected animals. However, significant 1, 2) or sciatic nerve (lanes 3, 4) of wild-type (lanes 1, 3) and Plp jp (lanes 2, 4) males were analyzed for levels of b-gal and PLP. Significantly different amounts of protein from brain (7 lg) and sciatic nerve (100 lg) were loaded for analysis on the same blot. The blot was analyzed first for PLP using the M2 anti-PLP-specific antibody (1:500), then stripped and incubated with an antibody against b-gal (1:1,000). [The apparent increase in b-gal expression in normal sciatic nerve relative to normal brain simply reflects the significant increase in the amount of protein analyzed.] B: Proteins (30 lg) isolated from brain (lanes 1, 2) or sciatic nerve (lanes 3, 4) of wild-type (lanes 1, 3) and Plp jp (lanes 2, 4) males were analyzed for MBP and b-actin. The blot was analyzed first for MBP using an anti-MBP antibody (1:500), then stripped and incubated with an antib-actin (1:250) primary antibody numbers of GC+ oligodendrocytes are present in these animals [35, 37] , and transcription of glycerol phosphate dehydrogenase, an early marker of oligodendrocyte differentiation, is unaffected [5] . In contrast, genes such as Plp, Mbp, and Mog (myelin/oligodendrocyte glycoprotein), whose expression is upregulated late in the oligodendrocyte differentiation program, are expressed at lower levels in the Plp jp CNS [5, 36, 38] , much like the PLP(+)Z transgene. Thus it appears that it is the ability of the cells to fully differentiate, and hence express high levels of gene products found in mature oligodendrocytes that is compromised in the Plp jp mutant. This concept is consistent with the observation that Plp jp oligodendrocytes expressing the PLP(+)Z transgene were morphologically immature (Fig. 3) . Previous studies [5] have shown that Plp gene transcription, in brain, is reduced in affected mice, with Plp jp mice at P25 having similar levels of Plp transcription as wild-type mice at P7. Other studies [38] have shown that the pattern of myelin gene expression in Plp jp oligodendrocytes is consistent with that found in immature wild-type cells. Thus, consistent with much data in the literature, expression of the PLP(+)Z transgene is reduced in the Plp jp CNS due to the immature status of oligodendrocytes in these animals.
Downregulation of the Plp gene and the PLP(+)Z transgene in Schwann cells
Few studies have assessed Plp gene regulation in the PNS. In contrast to the CNS, the Plp jp mutation in the PNS does not cause abnormal Schwann cell development or dysmyelination [39, 40] . However, expression of the PLP(+)Z transgene in the PNS, as well as the endogenous Plp gene, were decreased in Plp jp sciatic nerve relative to wild-type, while MBP levels were unaffected (Fig. 6 ). Since there are no overt pleiotropic effects of the Plp jp mutation in the PNS, the decreased levels of b-gal and PLP in the Plp jp PNS must be due to (Plp) regulatory sequences common to both the transgene and the endogenous gene, or to the shared nucleotide or amino acid sequence (13 N-terminal residues of PLP) between the mRNAs and proteins they encode. On the other hand, the mutated Plp jp PLP protein could conceivably participate in a negative feedback loop, decreasing its own expression, as well as that of the transgene. Since the PLP/DM20 C-terminus portion is out of frame in the mutant, it is possible that a nuclear localization signal (NLS) might have inadvertently been created. However, neither Plp jp PLP nor wild-type PLP contains an NLS when analyzed with a program that searches for NLS (http:// cubic.bioc.columbia.edu/predictNLS) [41, 42] . Furthermore Anderson et al. [40] It is striking that there was a more precipitous drop in transgene mRNA than Plp/Dm20 mRNA gene in Plp jp mice, relative to wild-type. This was true in both the CNS and PNS, and may result from greater stability of Plp/Dm20 transcripts than transgene mRNA. Previous studies indicate that the Plp-specific sequence, which is absent from Dm20 mRNA, and the 3¢-untranslated region of the Plp/Dm20 mRNA are important for stability of Plp gene transcripts in glial cells [15, 43, 44] . Since neither of these sequences is present in the transgene mRNA, amounts of the PLP(+)Z transcript are a true reflection of the transcriptional activity. Thus, the greater loss of transgene mRNA than Plp/Dm20 mRNAs in both the CNS and PNS in Plp jp mice relative to wild type is probably due, entirely, to a decrease in PLP(+)Z transcription initiation.
The downregulation of Plp/Dm20 mRNAs was less in Schwann cells than in oligodendrocytes. The stabilization elements that have been identified in the Plp mRNA particularly stabilize this mRNA in myelinating Schwann cells [43] . Thus, it is possible that since there is no loss of myelin in Plp jp peripheral nerve, the stabilization signals actively maintain Plp/Dm20 mRNAs. Since, as noted above, those stabilization elements are not present in the transgene mRNA, the decrease in PLP(+)Z mRNA levels would solely reflect a decrease in transcriptional activity.
It is unclear whether the reduction in expression of the transgene and the endogenous Plp gene in Plp jp mice results from expression of mutated PLP or DM20, or both. Unfortunately the only antibody available to detect DM20 protein by Western blot analysis recognizes a C-terminal epitope, which is altered in Plp jp PLP/DM20 proteins. Thus, only the mutant PLP protein in Plp jp mice could be examined due to the existence of PLP-specific antibodies [21] . Although the amounts, if any, of mutant DM20 in Plp jp sciatic nerve could not be determined, the PCR data (Fig. 7B (Figs. 4 and 5) . PLP and DM20 proteins are processed through the endoplasmic reticulum (ER) and Golgi membranes. Thus, as reported in other studies, the mutant proteins encoded by the Plp jp gene likely cannot fold correctly and are prevented from moving further through the intracellular transport pathway [9, 45] . As mentioned earlier, the PLP(+)Z transgene encodes a protein that contains the 13 Nterminal amino acids of PLP/DM20. We have shown that the transgene fusion protein is trafficked to compact CNS myelin, presumably by these PLP/ DM20 N-terminal residues [12] . Therefore, retention of Plp jp PLP/DM20 in the ER is a dominant effect, likely mediated by amino acids other than those at the N-terminus, since the transgene protein containing those amino acids was able to move through the ER and Golgi and out into the processes of Plp jp oligodendrocytes. Thus the movement of PLP/DM20 into the myelin membrane appears to be controlled substantially differently from that of other membrane proteins such as the acetylcholine receptor, in which N-terminal sequences are essential for the initial formation of a protein complex that then can be sorted to the appropriate membrane [46] .
In summary, results presented here suggest that expression of the PLP(+)Z transgene is an excellent prognosticator of Plp promoter activity, even in Plp jp mice. While expression of the transgene was decreased in both the CNS and PNS of Plp jp mice relative to that in wild-type littermates, the decrease in Schwann cells occurred in the absence of any overt pleiotropic effects. MBP levels in the PNS were unaffected, unlike the CNS, where the levels dropped in Plp jp mice. Thus, expression of Plp jp PLP/DM20 protein must signal indirectly and feedback to control Plp transcriptional activity, decreasing expression of the Plp jp gene as well as the transgene in the PNS, without affecting the expression of other myelin genes. Whether a similar signaling pathway exists in the CNS is obscured by the death of mature oligodendrocytes and the failure of immature oligodendrocytes to fully mature in the Plp jp mutant, but may well also be responsible for their decreased expression in the Plp jp CNS. The mechanisms mediating the feedback downregulation remain to be determined.
